Actemra Approved for Certain Blood Vessel Inflammation

MONDAY, May 22, 2017 — The injected drug Actemra (tocilizumab) has been approved by the U.S. Food and Drug Administration to treat adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis).
In a media release Monday, the…
Source: Topamax